You are Trying to View a Premium ArticleDaily News You Can't Find Anywhere Else
Lupin Bets Big on Oncology in AbbVie-Partnership, Could Garner $1 Billion+, an Industrial Info Market Brief
Industry Segment: Pharmaceutical & Biotech | Word Count: 113 Words
Attachment: Lupin Pharma 0119
Indian pharmaceutical company Lupin Limited is eyeing major growth in its portfolio through a Novel Drug Discovery and Development (NDDD) program, focused on oncology, immunology and metabolic disorders
This Premium Article can be purchased individually or as part of a subscription
Subscribe Now! All Fields Required...
- Join Industrial Info for Our Global Industrial Predictive Analytics Using M...
- Biosimilar vs. Generic Pharmaceuticals, an Industrial Info Market Brief
- Thanks to Brexit, EMA Exits London for Amsterdam in March, an Industrial In...
- Alembic Pharma's Portfolio to Boom in 2019, an Industrial Info News Alert
- Investment in Medical Cannabis Increases in Portugal, an Industrial Info Ma...
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker